Skip to main content

CD

0
Pipeline Programs
6
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Gilead Sciences
Gilead SciencesFOSTER CITY, CA
2 programs
ColonoscopyN/A
ColonoscopyN/A
Takeda
TakedaTOKYO, Japan
2 programs
ColonoscopyN/A2 trials
ColonoscopyN/A
Active Trials
NCT00645801Completed158Est. Jul 2011
NCT00611442Completed191Est. Jan 2008
Bristol Myers Squibb
2 programs
ColonoscopyN/A
ColonoscopyN/A
Kite Pharma
Kite PharmaCA - El Segundo
2 programs
ColonoscopyN/A1 trial
ColonoscopyN/A1 trial
Active Trials
NCT03487900Unknown320Est. Dec 2023
NCT03498625Completed240Est. Dec 2021
AbbVie
AbbVieNORTH CHICAGO, IL
2 programs
ColonoscopyN/A
ColonoscopyN/A
Biogen
BiogenCAMBRIDGE, MA
1 program
ColonoscopyN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TakedaColonoscopy
Kite PharmaColonoscopy
Kite PharmaColonoscopy
TakedaColonoscopy

Clinical Trials (4)

Total enrollment: 909 patients across 4 trials

NCT00645801TakedaColonoscopy

Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation

Start: Mar 2008Est. completion: Jul 2011158 patients
Phase 4Completed
NCT03487900Kite PharmaColonoscopy

Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up

Start: Mar 2018Est. completion: Dec 2023320 patients
N/AUnknown
NCT03498625Kite PharmaColonoscopy

Crohn's Disease Endoscopic REmission Definition in an Objective Way

Start: Mar 2018Est. completion: Dec 2021240 patients
N/ACompleted
NCT00611442TakedaColonoscopy

Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy

Start: Oct 2007Est. completion: Jan 2008191 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.